August 1, 2024
Nano PharmaSolutions is thrilled to introduce interim Chief Operating Officer, William Martin. Bill has 15 years of experience in drug development, working to grow innovative companies by securing financing and strategic partnerships. Bill brings a unique perspective, combining financial expertise with operational excellence to NPS as we embark on our first clinical trial of NT-301 for Parkinson’s Disease. engagement to help conceive and launch LSO. Along with fellow panelists from Cadenza Bio, OKBioStart and Arrowpoint Labs, Russell spoke to an audience of life science founders about essential elements for company growth, including options for fractional and interim executive leadership.